Valdecoxib

Valdecoxib, also known as SC-65872, is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is a selective cyclooxygenase-2 inhibitor. It was approved in 2001 to treat arthritis and menstrual cramps. It was withdraw in 2005.

Product information

CAS Number: 181695-72-7

Molecular Weight: 314.36

Formula: C16H14N2O3S

Synonym:

Bextra

SC 65872

Chemical Name: 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide

Smiles: CC1ON=C(C=1C1C=CC(=CC=1)S(N)(=O)=O)C1C=CC=CC=1

InChiKey: LNPDTQAFDNKSHK-UHFFFAOYSA-N

InChi: InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.